Tiotropium Bromide/Olodaterol (Stiolto Respimat): Once-Daily Combination Therapy for the Maintenance of COPD

Tiotropium bromide/olodaterol (Stiolto Respimat): once-daily combination therapy for the maintenance of COPD.

Saved in:
Bibliographic Details
Published inP&T (Lawrenceville, N.J.) Vol. 41; no. 2; pp. 97 - 102
Main Authors Mosley, 2nd, Juan F, Smith, Lillian L, Dutton, Brittany N
Format Journal Article
LanguageEnglish
Published United States MediMedia USA, Inc 01.02.2016
Subjects
Departments
Stiolto Respimat
beta2 agonist
tiotropium bromide
anti-cholinergic
COPD
olodaterol
Online AccessGet full text

Cover

Abstract Tiotropium bromide/olodaterol (Stiolto Respimat): once-daily combination therapy for the maintenance of COPD.
AbstractList Tiotropium bromide/olodaterol (Stiolto Respimat): once-daily combination therapy for the maintenance of COPD.
Tiotropium bromide/olodaterol (Stiolto Respimat): once-daily combination therapy for the maintenance of COPD
Author Dutton, Brittany N
Smith, Lillian L
Mosley, 2nd, Juan F
Author_xml – sequence: 1
  givenname: Juan F
  surname: Mosley, 2nd
  fullname: Mosley, 2nd, Juan F
– sequence: 2
  givenname: Lillian L
  surname: Smith
  fullname: Smith, Lillian L
– sequence: 3
  givenname: Brittany N
  surname: Dutton
  fullname: Dutton, Brittany N
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26908999$$D View this record in MEDLINE/PubMed
BookMark eNpVkF1LwzAUhnsxcXP6FySX86KYjyVNvBC08wsmFZ3XJU1TF0mTmqbC_r0Fp-jVgXMenpfzHiUT552eJDMEKU4RyfA0Oer7dwjpknBxmEwxE5ALIWaJ3Rgfg-_M0ILr4FtT6_PC-lpGHbwFi5dovI0ePOu-M62MZxegcEqnK2nsDuS-rYyTI-PAZquD7Hag8QHErQaP0rionRxp4BuQF0-r4-SgkbbXJ_s5T15vbzb5fbou7h7yq3XaIY5iyjjDXJMM1g1RqslqxTFnTVXxbNxQVIlGKdIQoQjNMIUVRrWuUUW54FhAQubJ5be3G6pW10q7GKQtuzB-EHall6b8f3FmW775z3KZLSkjbBQs9oLgPwbdx7I1vdLWSqf90JcoYxwxBhkd0dO_Wb8hPxWTLzo4ep4
ContentType Journal Article
Copyright Copyright © 2016, MediMedia USA, Inc. 2016
Copyright_xml – notice: Copyright © 2016, MediMedia USA, Inc. 2016
DBID NPM
7X8
5PM
DatabaseName PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EndPage 102
ExternalDocumentID 26908999
Genre Journal Article
GroupedDBID ---
04C
123
29O
2WC
53G
AAWTL
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BMSDO
DIK
E3Z
EBS
EIHBH
EJD
F5P
HYE
LSO
NPM
OK1
RPM
SJN
TR2
7X8
5PM
ID FETCH-LOGICAL-p181t-68628e370df3ccf7dc8286fbb87df351b9fcc3f39c357250b21ded1b589829033
IEDL.DBID RPM
ISSN 1052-1372
IngestDate Fri Sep 01 02:36:02 EDT 2023
Fri Apr 12 08:33:09 EDT 2024
Thu May 23 23:22:26 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Stiolto Respimat
beta2 agonist
tiotropium bromide
anti-cholinergic
COPD
olodaterol
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p181t-68628e370df3ccf7dc8286fbb87df351b9fcc3f39c357250b21ded1b589829033
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Disclosure: The authors report no commercial or financial interests in regard to this article.
Dr. Mosley and Dr. Smith are Assistant Professors of Pharmacy Practice at the Florida Agricultural and Mechanical University, College of Pharmacy and Pharmaceutical Sciences, in Crestview, Florida. Brittany Dutton is a Doctor of Pharmacy candidate at that institution. Drug Forecast is a regular column coordinated by Alan Caspi, PhD, PharmD, MBA, President of Caspi & Associates in New York, New York.
PMID 26908999
PQID 1768166065
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4745636
proquest_miscellaneous_1768166065
pubmed_primary_26908999
PublicationCentury 2000
PublicationDate 2016-Feb
20160201
PublicationDateYYYYMMDD 2016-02-01
PublicationDate_xml – month: 02
  year: 2016
  text: 2016-Feb
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle P&T (Lawrenceville, N.J.)
PublicationTitleAlternate P T
PublicationYear 2016
Publisher MediMedia USA, Inc
Publisher_xml – name: MediMedia USA, Inc
References 25573406 - Eur Respir J. 2015 Apr;45(4):969-79
15826532 - Arch Bronconeumol. 2005 Apr;41(4):220-9
12947145 - Thorax. 2003 Sep;58(9):803-8
References_xml
SSID ssj0054389
Score 2.0871139
Snippet Tiotropium bromide/olodaterol (Stiolto Respimat): once-daily combination therapy for the maintenance of COPD.
Tiotropium bromide/olodaterol (Stiolto Respimat): once-daily combination therapy for the maintenance of COPD
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 97
SubjectTerms Departments
Title Tiotropium Bromide/Olodaterol (Stiolto Respimat): Once-Daily Combination Therapy for the Maintenance of COPD
URI https://www.ncbi.nlm.nih.gov/pubmed/26908999
https://search.proquest.com/docview/1768166065
https://pubmed.ncbi.nlm.nih.gov/PMC4745636
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF7anryIb-ujRJCi0DTZbDabHKVYqlIt2kJvIbubxUDzoE0P_ffu5mGtePKSQ7IhYXbIfF9m5hsAbmngcvmCQncQD3SbykMACdQpFZ5pCpcFxX_I8aszmtnPczxvAFz3whRF-4xG_WQR95Pos6itzGJm1HVixmQ8sIkM-8gxmqApHbSm6OXnF6tx3kWKE1s6RESNq7GcIrv1J4r8XQz5I7oMD8B-BQu1h_Lxh6ARJkegOyl1pTc9bbptk1r1tK422SpOb46BOY3SfJlm0TrWJK-OIx4ab4tUkfllutDuPlRzUZ5q7yqvLiHq_QmYDR-ng5FejULQMxmCc131cbghIiYXiDFBOFPt34JSl8gzGFJPMIYE8hjCRKIaakEeckix66lMKUKnoJWkSXgONMyIZQeuzaGgts0x9aAXOCayMaYQOawNbmoj-dLVVP4gSMJ0vfKhpCbQkYwHt8FZaTQ_KzUx_NrEbUB2zPm9QMlY716Ru1vIWVe7efHvOy_BnoQxVS31FWjly3V4LaFCTjsSJD-9dAoH-QLzrMRJ
link.rule.ids 230,315,730,783,787,888,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZgHODC-zGeRUIIJLo1S9K0R4RA4zGYYCBuVZM0omJrp607jF9P0q68xAUuPTStZNlp_Tn-bAMc8NCTWkBlu1iGNuH6EiKGbM6V7zjKE2F-Dtm6dZuP5OqZPk8BLWthctK-4HEt6fZqSfyScyv7PVEveWL1duuMMO32sVufhhn9vTqkDNKLHzA1A73zJCdt2AgzM7Cm4eb5rV9x5E865Bf_crEAT6VkBa3ktTbKeE28_Wja-GfRF2F-gjit02J5CaaiZBkO20XL6vGJ1fmswBqeWIdW-7OZ9XgFnE6cZoO0H496lg7Ze7GM6nfd1JwTDNKudfRg6pay1Lo3KXuNfo9X4fHivHPWtCdTFuy-9u6ZbUpEvAgzRyoshGJSmMpyxbnH9B2KuK-EwAr7AlOmARNvIBlJxKnnmyQsxmtQSdIk2gCLCtYgoUckUpwQSbmP_NB1MKGUI-yKKuyX2g_0LjapiTCJ0tEwQDrqQa4OpmgV1gtrBP2i3UZQ2q4K7JudPh4wHbK_r2jt552yJ9re_PebezDb7LRugpvL2-stmNNoaULZ3oZKNhhFOxqRZHw333_vlUzlSQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bT4MwFD7xkhhfvF_mFROzaCKDrpTCo5kuXueiMzG-ENrSSNyATPagv94Whk7jky88QEkaTsv5Ts93vgNwyEJPqAlK08UiNB2mLiGiyGRM-rYtPR4W55C3Hffi0bl6Ik8Trb4K0j5ncSPpDxpJ_FJwK7MBtyqemNW9bTlUuX3sWpmQ1jTMqj1ru1WgXv6EiW7qXSQ6SdNEmOqmNU23yHH9iSV_UyInfEx7EZ6r2ZXUktfGKGcN_vFLuPFf01-ChTHyNE7LIcswFSUrUO-W0tXvJ0bvuxLr7cSoG91vUev3VbB7cZoP0yweDQwVug9iEVl3_VSfFwzTvnH0oOuX8tS416l7hYKP1-Cxfd5rXZjjbgtmprx8bupSES_C1BYScy6p4LrCXDLmUXWHIOZLzrHEPseEKuDEmkhEAjHi-ToZi_E6zCRpEm2CQThtOqHnCCSZ4wjCfOSHro0dQhjCLq_BQWWBQK1mnaIIkygdvQVIRT_IVUEVqcFGaZEgK2U3gsp-NaA_bPU1QCtl_3yiLFAoZo-_-Na_39yHue5ZO7i57Fxvw7wCTWPm9g7M5MNRtKuASc72iiX4Cchp58k
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tiotropium+Bromide%2FOlodaterol+%28Stiolto+Respimat%29&rft.jtitle=P%26T+%28Lawrenceville%2C+N.J.%29&rft.au=Mosley%2C+Juan+F.&rft.au=Smith%2C+Lillian+L.&rft.au=Dutton%2C+Brittany+N.&rft.date=2016-02-01&rft.pub=MediMedia+USA%2C+Inc&rft.issn=1052-1372&rft.volume=41&rft.issue=2&rft.spage=97&rft.epage=102&rft_id=info%3Apmid%2F26908999&rft.externalDBID=PMC4745636
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1052-1372&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1052-1372&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1052-1372&client=summon